Company Filing History:
4 out of 961 
1 out of 810 
Years Active: 2022-2025
Title: Tal Gilboa: Innovator in Genomic Detection Technologies
Introduction
Tal Gilboa is a prominent inventor based in Haifa, Israel. He has made significant contributions to the field of genomic detection, holding a total of 4 patents. His work focuses on developing advanced methods and compositions for identifying genetic variations, which can have profound implications for clinical diagnostics.
Latest Patents
One of Tal Gilboa's latest patents is titled "Compositions and methods for detection of genomic variations." This invention involves compositions, kits, and methods designed for the detection and classification of genetic variations. The methods leverage the specificity of a ligation reaction combined with the single-molecule sensitivity of nanopore biosensors. This innovative approach enables the clinical detection of various diseases, including bacterial infections and cancer, by identifying specific genetic alterations. Another notable patent is related to "Nanopore fabrication," which describes systems that include a light source, a thin membrane immersed in an aqueous solution, and a mechanism to direct and focus light onto the membrane. This patent also covers methods for thinning and etching membranes, as well as membranes featuring a nanopore with a Gaussian curve-shaped cross-section.
Career Highlights
Throughout his career, Tal Gilboa has worked with esteemed organizations such as the Technion Research & Development Foundation Limited and Ramot at Tel-Aviv University Ltd. His innovative work has positioned him as a key figure in the field of genomic research and technology.
Collaborations
Tal has collaborated with notable individuals in his field, including Amit Meller and Michelle Patkin. These partnerships have further enhanced his research and development efforts.
Conclusion
Tal Gilboa's contributions to genomic detection technologies exemplify the impact of innovation in healthcare. His patents and collaborations reflect a commitment to advancing scientific understanding and improving clinical diagnostics.